Clinical Trials
11 trialsNCT07609940 2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4 Not yet recruiting
NCT07599137 2026-05-20
ADES
Peking University Cancer Hospital & Institute
Phase 4 Not yet recruiting
NCT07600164 2026-05-20
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Peking University People's Hospital
Phase 4 Not yet recruiting
NCT07303816 2026-05-18
STAT-CAT
Brigham and Women's Hospital
Phase 4 Not yet recruiting
NCT07583134 2026-05-15
B-BIT
Seoul St. Mary's Hospital
Phase 4 Not yet recruiting
NCT07589699 2026-05-15
Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP
The First Affiliated Hospital with Nanjing Medical University
Phase 4 Not yet recruiting
NCT07590648 2026-05-15
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
Phase 4 Not yet recruiting
NCT07587749 2026-05-14
Skin Subs vs Secondary Intention
Baylor Research Institute
Phase 4 Not yet recruiting
NCT07462663 2026-05-13
SHAPE-ENDO
Hospital Universitari de Bellvitge
Phase 4 Not yet recruiting
NCT07574047 2026-05-07
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
Swiss Cancer Institute
Phase 4 Not yet recruiting
NCT07569926 2026-05-06
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Blue Earth Diagnostics
Phase 4 Not yet recruiting